by Neeraj Jain | Oct 19, 2026 | General
DXC Technology Company (NYSE:DXC) stock is trading higher Monday following reports that the company is in advanced talks to sell its insurance software business to private investment firm Eldridge Industries for $2.4 billion. Reuters reported Monday, citing people...
by Evette Mitkov | Oct 19, 2026 | General
Xanadu Quantum Technologies Ltd. (TSX:XNDU) shares are sliding Monday after an early pop, despite news of provisional DARPA funding. Here’s what you should know. Xanadu Quantum stock is testing key support levels. Why are XNDU shares at support? Xanadu Pulls Back...
by Piero Cingari | Oct 19, 2026 | General
In April 2020, with most of America locked indoors, the country’s home builders recorded their darkest mood in eight years. Six years later, with no virus and no lockdown, they feel even worse. The NAHB/Wells Fargo Housing Market Index (HMI), a monthly survey tracking...
by Vandana Singh | Oct 19, 2026 | General
The U.S. Food and Drug Administration (FDA) on Monday granted accelerated approval to GSK plc (NYSE:GSK) for Jemperli (dostarlimab-gxly), making it the first and only immunotherapy for adults with stage II and III mismatch repair deficient (dMMR) or microsatellite...
by Vandana Singh | Oct 19, 2026 | General
Gilead Sciences Inc. (NASDAQ:GILD) on Monday announced 12-week induction data from its Phase 2 SWIFT trial evaluating emvistegrast, an investigational once-daily oral treatment for adults with moderately to severely active ulcerative colitis. The biopharmaceutical...
Recent Comments